Diabetic foot ulcers - Practical treatment recommendations

被引:46
作者
Edmonds, Michael [1 ]
机构
[1] Kings Coll Hosp London, Diabet Foot Clin, London SE5 9RS, England
关键词
D O I
10.2165/00003495-200666070-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
When treating diabetic foot ulcers it is important to be aware of the natural history of the diabetic foot, which can be divided into five stages: stage 1, a normal foot; stage 2, a high risk foot; stage 3, an ulcerated foot; stage 4, an infected foot; and stage 5, a necrotic foot. This covers the entire spectrum of foot disease but emphasises the development of the foot ulcer as a pivotal event in stage 3, which demands urgent and aggressive management. Diabetic foot care in all stages needs multidisciplinary management to control mechanical, wound, microbiological, vascular, metabolic and educational aspects. Achieving good metabolic control of blood glucose, lipids and blood pressure is important in each stage, as is education to teach proper foot care appropriate for each stage. Ideally, it is important to prevent the development of ulcers in stages 1 and 2. In stage 1, the normal foot, it is important to encourage the use of suitable footwear, and to educate the patient to promote healthy foot care and footwear habits. In stage 2, the foot has developed one or more of the following risk factors for ulceration: neuropathy, ischaemia, deformity, swelling and callus. The majority of deformities can be accommodated in special footwear and as callus is an important precursor of ulceration it should be treated aggressively, especially in the neuropathic foot. In stage 3, ulcers can be divided into two distinct entities: those in the neuropathic foot and those in the neuroischaemic foot. In the neuropathic foot, ulcers commonly develop on the plantar surface of the foot and the toes, and are associated with neglected callus and high plantar pressures. In the neuroischaemic foot, ulcers are commonly seen around the edges of the foot, including the apices of the toes and back of the heel, and are associated with trauma or wearing unsuitable shoes. Ulcers in stage 3 need relief of pressure (mechanical control), sharp debridement and dressings (wound control), and neuroischaemic foot ulcers may need vascular intervention (vascular control). In stage 4, microbiological control is crucial and severe infections need intravenous antibacterial therapy, and urgent assessment of the need for surgical drainage and debridement. Without urgent treatment, severe infections will progress to necrosis. In stage 5, necrosis can be divided into wet and dry necrosis. Wet necrosis in neuropathic feet requires intravenous antibacterials and surgical debridement, and wet necrosis in neuroischaemic feet also needs vascular reconstruction. Aggressive management of diabetic foot ulceration will reduce the number of feet proceeding to infection and necrosis, and thus reduce the number of major amputations in diabetic patients.
引用
收藏
页码:913 / 929
页数:17
相关论文
共 86 条
[1]   Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration [J].
Abbott, CA ;
Vileikyte, L ;
Williamson, S ;
Carrington, AL ;
Boulton, AJM .
DIABETES CARE, 1998, 21 (07) :1071-1075
[2]   Maggot therapy in "Lower-extremity hospice" wound care - Fewer amputations and more antibiotic-free days [J].
Armstrong, DG ;
Short, B ;
Martin, BR ;
Kimbriel, HR ;
Nixon, BP ;
Boulton, AJM .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2005, 95 (03) :254-257
[3]   Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial [J].
Armstrong, DG ;
Lavery, LA .
LANCET, 2005, 366 (9498) :1704-1710
[4]   Off-loading the diabetic foot wound - A randomized clinical trial [J].
Armstrong, DG ;
van Schie, CHM ;
Nguyen, HC ;
Boulton, AJM ;
Lavery, LA ;
Harkless, LB .
DIABETES CARE, 2001, 24 (06) :1019-1022
[5]   Treatment of chronic wounds with bone marrow-derived cells [J].
Badiavas, EV ;
Falanga, V .
ARCHIVES OF DERMATOLOGY, 2003, 139 (04) :510-516
[6]  
BAKKER K, 2005, DIABETES FOOT CARE T
[7]   Therapeutic footwear in diabetes - The good, the bad, and the ugly? [J].
Boulton, AJM ;
Jude, EB .
DIABETES CARE, 2004, 27 (07) :1832-1833
[8]   The diabetic foot: from art to science - The 18th Camillo Golgi lecture [J].
Boulton, AJM .
DIABETOLOGIA, 2004, 47 (08) :1343-1353
[9]   Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers - A randomized study [J].
Caravaggi, C ;
Faglia, E ;
De Giglio, R ;
Mantero, M ;
Quarantiello, A ;
Sommariva, E ;
Gino, M ;
Pritelli, C ;
Morabito, A .
DIABETES CARE, 2000, 23 (12) :1746-1751
[10]   Treatment for diabetic foot ulcers [J].
Cavanagh, PR ;
Lipsky, BA ;
Bradbury, AW ;
Botek, G .
LANCET, 2005, 366 (9498) :1725-1735